Charles River Laboratories International (CRL) Asset Writedowns and Impairment (2022 - 2025)

Charles River Laboratories International's Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $7.9 million for Q4 2025.

• In Q4 2025, Asset Writedowns and Impairment fell 70.8% year-over-year to $7.9 million; the TTM figure through Dec 2025 stood at $12.4 million (down 64.67% YoY), while the FY2025 annual figure was $12.4 million, down 15.77% from the prior year.
• Asset Writedowns and Impairment was $7.9 million for Q4 2025 at Charles River Laboratories International, up from -$26.6 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $29.2 million in Q2 2025 to a low of -$26.6 million in Q3 2025.
• Historically, Asset Writedowns and Impairment has averaged $5.6 million across 4 years, with a median of $6.7 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment jumped 1543.21% in 2024, then slumped 342.08% in 2025.
• A 4-year view of Asset Writedowns and Impairment shows it stood at $6.7 million in 2022, then plunged by 218.95% to -$8.0 million in 2023, then jumped by 438.47% to $27.0 million in 2024, then tumbled by 70.8% to $7.9 million in 2025.
• The last three Asset Writedowns and Impairment figures came in at $7.9 million (Q4 2025), -$26.6 million (Q3 2025), and $29.2 million (Q2 2025), per Business Quant data.